Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Forrest

Showing results (121-130 of 177) with videos related to

Pageof 18
Sort By:
Diagnostic Microbiology and Infectious Disease|August 26, 2006
Pharmacodynamics of cefprozil against Haemophilus influenzae in an in vitro pharmacodynamic modelPatrick F Smith, Brian Tsuji, Brent M Booker, et al.
Antimicrobial Agents and Chemotherapy|December 22, 2017
Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling of Aerosolized Colistin in a Mouse Lung Infection ModelYu-Wei Lin, Qi Tony Zhou, Mei-Ling Han, et al.
Therapeutic Drug Monitoring|May 6, 2011
Therapeutic drug monitoring of protease inhibitors and efavirenz in HIV-infected individuals with active substance-related disordersQing Ma, Barry S Zingman, Amneris E Luque, et al.
Data in Brief|March 15, 2017
Data report on inflammatory C-C chemokines among insulin-using women with diabetes mellitus and breast cancerZachary A P Wintrob, Jeffrey P Hammel, George K Nimako, et al.
International Journal of Antimicrobial Agents|July 25, 2016
Combinatorial pharmacodynamics of polymyxin B and tigecycline against heteroresistant Acinetobacter baumanniiGauri G Rao, Neang S Ly, John Diep, et al.
Scientific Reports|May 20, 2016
Polymyxin Resistance in Acinetobacter baumannii: Genetic Mutations and Transcriptomic Changes in Response to Clinically Relevant Dosage RegimensSoon-Ee Cheah, Matthew D Johnson, Yan Zhu, et al.
British Journal of Clinical Pharmacology|April 30, 2014
Optimal sampling of antipsychotic medicines: a pharmacometric approach for clinical practiceVidya Perera, Robert R Bies, Gary Mo, et al.
Clinical Pharmacokinetics|October 10, 2012
Pharmacokinetic modelling of efavirenz, atazanavir, lamivudine and tenofovir in the female genital tract of HIV-infected pre-menopausal womenJulie B Dumond, Melanie R Nicol, Racheal N Kendrick, et al.
International Journal of Antimicrobial Agents|October 25, 2016
Comparative pharmacodynamics of four different carbapenems in combination with polymyxin B against carbapenem-resistant Acinetobacter baumanniiJustin R Lenhard, Jonathan S Gall, Jurgen B Bulitta, et al.
Antimicrobial Agents and Chemotherapy|February 7, 2007
Compartmental pharmacokinetic analysis of oral amprenavir with secondary peaksOlanrewaju Okusanya, Alan Forrest, Robin DiFrancesco, et al.
Pageof 18

Showing results (121-130 of 177) with videos related to

Sort By:
Pageof 18
Diagnostic Microbiology and Infectious Disease|August 26, 2006
Pharmacodynamics of cefprozil against Haemophilus influenzae in an in vitro pharmacodynamic modelPatrick F Smith, Brian Tsuji, Brent M Booker, et al.
Antimicrobial Agents and Chemotherapy|December 22, 2017
Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling of Aerosolized Colistin in a Mouse Lung Infection ModelYu-Wei Lin, Qi Tony Zhou, Mei-Ling Han, et al.
Therapeutic Drug Monitoring|May 6, 2011
Therapeutic drug monitoring of protease inhibitors and efavirenz in HIV-infected individuals with active substance-related disordersQing Ma, Barry S Zingman, Amneris E Luque, et al.
Data in Brief|March 15, 2017
Data report on inflammatory C-C chemokines among insulin-using women with diabetes mellitus and breast cancerZachary A P Wintrob, Jeffrey P Hammel, George K Nimako, et al.
International Journal of Antimicrobial Agents|July 25, 2016
Combinatorial pharmacodynamics of polymyxin B and tigecycline against heteroresistant Acinetobacter baumanniiGauri G Rao, Neang S Ly, John Diep, et al.
Scientific Reports|May 20, 2016
Polymyxin Resistance in Acinetobacter baumannii: Genetic Mutations and Transcriptomic Changes in Response to Clinically Relevant Dosage RegimensSoon-Ee Cheah, Matthew D Johnson, Yan Zhu, et al.
British Journal of Clinical Pharmacology|April 30, 2014
Optimal sampling of antipsychotic medicines: a pharmacometric approach for clinical practiceVidya Perera, Robert R Bies, Gary Mo, et al.
Clinical Pharmacokinetics|October 10, 2012
Pharmacokinetic modelling of efavirenz, atazanavir, lamivudine and tenofovir in the female genital tract of HIV-infected pre-menopausal womenJulie B Dumond, Melanie R Nicol, Racheal N Kendrick, et al.
International Journal of Antimicrobial Agents|October 25, 2016
Comparative pharmacodynamics of four different carbapenems in combination with polymyxin B against carbapenem-resistant Acinetobacter baumanniiJustin R Lenhard, Jonathan S Gall, Jurgen B Bulitta, et al.
Antimicrobial Agents and Chemotherapy|February 7, 2007
Compartmental pharmacokinetic analysis of oral amprenavir with secondary peaksOlanrewaju Okusanya, Alan Forrest, Robin DiFrancesco, et al.
Pageof 18